JAN 02, 2017 12:38 PM PST

Chinese Herbal Treatment for Malaria can Disrupt TB

WRITTEN BY: Carmen Leitch

In a study published in Nature Chemical Biology, researchers demonstrated that an herbal remedy used for centuries in Chinese medicine could potentially improve the treatment of tuberculosis. The remedy, artemisinin is effective against malaria, and the new work shows that it can disrupt the ability of the Mycobacterium tuberculosis bacterium (Mtb), which causes the disease, to go dormant, which is a part of why it can be so hard to treat. The study is described in the following video.

 

 

"When TB bacteria are dormant, they become highly tolerant to antibiotics," explained the leader of the work, Robert Abramovitch, a TB expert and Assistant Professor in the College of Veterinary Medicine at Michigan State University. "Blocking dormancy makes the TB bacteria more sensitive to these drugs and could shorten treatment times."

Tuberculosis remains a serious problem worldwide. According to the Centers for Disease Control, TB is declining in the United States, but there were still 9,557 new cases in 2015. The World Health Organization estimates that 10.4 million people were sickened by TB and 1.8 million died from the disease (including 0.4 million among people with HIV) in 2015 alone, putting it among the ten leading causes of death in the world.

Mtb requires oxygen for a successful existence inside the body. The immune system uses that to fight the bacterium, starving it of oxygen to get it under control. In their work, the investigators report that artemisinin attacks the heme molecule that is inside of the Mtb oxygen sensor. The artemisinin can more or less halt the action of the sensor by disrupting that molecule, and the pathogen can no longer tell how much oxygen there is in its environment.

"When the Mtb is starved of oxygen, it goes into a dormant state, which protects it from the stress of low-oxygen environments," Abramovitch said. "If Mtb can't sense low oxygen, then it can't become dormant and will die."

TB is able to remain in its dormant state, inside of the body, for decades. It is able exploit periods of weakness in the immune system, reawakening and causing illness again during those times. Abramovitch noted however that whether it wakes up or stays dormant, TB can require six months of treatment, one of the primary reasons why the disease is so difficult to control.

"Patients often don't stick to the treatment regimen because of the length of time it takes to cure the disease," he explained. "Incomplete therapy plays an important role in the evolution and spread of multi-drug resistant TB strains."

He suggested that this work could be key to shortening the therapeutic regimen because it can clear out the dormant, persistant bacteria. That in turn would lead to improved patient outcomes and a slowing of TB’s evolution into drug-resistance.

Over 540,000 different compounds were screened byAbramovitch’s team. They found five other chemical inhibitors that act on the Mtb oxygen sensor in different ways that may also be be effective in TB treatment.

"Two billion people worldwide are infected with Mtb," Abramovitch said. "TB is a global problem that requires new tools to slow its spread and overcome drug resistance. This new method of targeting dormant bacteria is exciting because it shows us a new way to kill it."

One winner of the 2015 Nobel Prize in Physiology or Medicine, Tu Youyou, speaks in the following video about her award-winning work, in which artemisinin was developed into a malaria treatment.

 

 

Sources: AAAS/Eurekalert! via MSU, CDC, WHO, Nature Chemical Biology

About the Author
  • Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
MAR 23, 2021
Microbiology
Pregnant Moms Easily Pass On COVID-19 Antibodies Through Placenta
MAR 23, 2021
Pregnant Moms Easily Pass On COVID-19 Antibodies Through Placenta
Recent work has shown that SARS-CoV-2 antibodies that are carried by a pregnant woman can cross the placenta and reach t ...
APR 01, 2021
Microbiology
Mapping the Wild Microbiome to Search for Therapeutic Agents
APR 01, 2021
Mapping the Wild Microbiome to Search for Therapeutic Agents
Many people think of bacteria as disgusting germs, but there are plenty of important bacterial species that provide us w ...
APR 19, 2021
Microbiology
Gas-Generating Microbes Highlight the Diet - Microbiome Link
APR 19, 2021
Gas-Generating Microbes Highlight the Diet - Microbiome Link
Researchers are learning more about how different species of bacteria in the human gut microbiome play a role in metabol ...
MAY 02, 2021
Microbiology
Fasting Alters Gut Microbiota, Lowering Blood Pressure
MAY 02, 2021
Fasting Alters Gut Microbiota, Lowering Blood Pressure
Increasingly, microbes in the gut are being linked to human health and disease. New research has suggested that disrupti ...
MAY 20, 2021
Clinical & Molecular DX
Gonorrhea Testing on the Go
MAY 20, 2021
Gonorrhea Testing on the Go
Forget lab-based tests—a new portable microfluidic device links to a mobile app, diagnosing gonorrhea in just 15 m ...
MAY 26, 2021
Coronavirus
Why Did the COVID-19 Lab Leak Theory Suddenly Gain Traction?
MAY 26, 2021
Why Did the COVID-19 Lab Leak Theory Suddenly Gain Traction?
Since the onset of the COVID-19 pandemic, there has been little doubt that the virus emerged somewhere in or around Wuha ...
Loading Comments...